AIM: To evaluate the effect of beta-blockade on angiotensins in the splanchnic and peripheral circulation of cirrhotic patients and also to compare hemodynamic parameters during liver transplantation according to propranolol pre-treatment or not. METHODS: Patients were allocated into two groups: outpatients with advanced liver disease(LD) and during liver transplantation(LT). Both groups were subdivided according to treatment with propranolol or not. Plasma was collected through peripheral venipuncture to determine plasma renin activity(PRA), Angiotensin(Ang) I, Ang II, and Ang-(1-7) levels by radioimmunoassay in LD group. During liver transplantation, hemodynamic parameters were determined and blood samples were obtained from the portal vein to measure renin angiotensin system(RAS) components. RESULTS: PRA, Ang I, Ang II and Ang-(1-7) were significantly lower in the portal vein and periphery in all subgroups treated with propranolol as compared to non-treated. The relationships between Ang-(1-7) and Ang I levels and between Ang II and Ang I were significantly increased in LD group receiving propranolol. The ratio between Ang-(1-7) and Ang II remained unchanged in splanchnic and peripheral circulation in patients under beta-blockade, whereas the relationship between Ang II and Ang I was significantly increased in splanchnic circulation of LT patients treated with propranolol. During liver transplantation, cardiac output and index as well systemic vascular resistance and index were reduced in propranolol-treated subgroup. CONCLUSION: In LD group, propranolol treatment reduced RAS mediators, but did not change the ratio between Ang-(1-7) and Ang II in splanchnic and peripheral circulation. Furthermore, the modification of hemodynamic parameters in propranolol treated patients was not associated with changes in the angiotensin ratio.
AIM: To evaluate the effect of beta-blockade on angiotensins in the splanchnic and peripheral circulation of cirrhotic patients and also to compare hemodynamic parameters during liver transplantation according to propranolol pre-treatment or not. METHODS:Patients were allocated into two groups: outpatients with advanced liver disease(LD) and during liver transplantation(LT). Both groups were subdivided according to treatment with propranolol or not. Plasma was collected through peripheral venipuncture to determine plasma renin activity(PRA), Angiotensin(Ang) I, Ang II, and Ang-(1-7) levels by radioimmunoassay in LD group. During liver transplantation, hemodynamic parameters were determined and blood samples were obtained from the portal vein to measure renin angiotensin system(RAS) components. RESULTS: PRA, Ang I, Ang II and Ang-(1-7) were significantly lower in the portal vein and periphery in all subgroups treated with propranolol as compared to non-treated. The relationships between Ang-(1-7) and Ang I levels and between Ang II and Ang I were significantly increased in LD group receiving propranolol. The ratio between Ang-(1-7) and Ang II remained unchanged in splanchnic and peripheral circulation in patients under beta-blockade, whereas the relationship between Ang II and Ang I was significantly increased in splanchnic circulation of LT patients treated with propranolol. During liver transplantation, cardiac output and index as well systemic vascular resistance and index were reduced in propranolol-treated subgroup. CONCLUSION: In LD group, propranolol treatment reduced RAS mediators, but did not change the ratio between Ang-(1-7) and Ang II in splanchnic and peripheral circulation. Furthermore, the modification of hemodynamic parameters in propranolol treated patients was not associated with changes in the angiotensin ratio.
Authors: Roberto J Groszmann; Guadalupe Garcia-Tsao; Jaime Bosch; Norman D Grace; Andrew K Burroughs; Ramon Planas; Angels Escorsell; Juan Carlos Garcia-Pagan; David Patch; Daniel S Matloff; Hong Gao; Robert Makuch Journal: N Engl J Med Date: 2005-11-24 Impact factor: 91.245
Authors: Ana Cristina Simões e Silva; Sérgio Veloso Brant Pinheiro; Regina Maria Pereira; Anderson José Ferreira; Robson Augusto Souza Santos Journal: Mini Rev Med Chem Date: 2006-05 Impact factor: 3.862
Authors: Regina Maria Pereira; Robson Augusto Souza Dos Santos; Mauro Martins Teixeira; Virginia Hora Rios Leite; Lincoln Paiva Costa; Filipi Leles da Costa Dias; Lucíola S Barcelos; Guilherme Birchal Collares; Ana Cristina Simões e Silva Journal: J Hepatol Date: 2006-11-27 Impact factor: 25.083
Authors: G Paizis; C Tikellis; M E Cooper; J M Schembri; R A Lew; A I Smith; T Shaw; F J Warner; A Zuilli; L M Burrell; P W Angus Journal: Gut Date: 2005-09-15 Impact factor: 23.059
Authors: Qi Fu; Tiffany B Vangundy; Shigeki Shibata; Richard J Auchus; Gordon H Williams; Benjamin D Levine Journal: Hypertension Date: 2011-06-20 Impact factor: 10.190
Authors: Walkíria Wingester Vilas-Boas; Antônio Ribeiro-Oliveira; Regina Maria Pereira; Renata da Cunha Ribeiro; Jerusa Almeida; Ana Paula Nadu; Ana Cristina Simões e Silva; Robson Augusto Souza dos Santos Journal: World J Gastroenterol Date: 2009-05-28 Impact factor: 5.742
Authors: Ana Cristina Simões E Silva; Aline S Miranda; Natália P Rocha; Antônio L Teixeira Journal: World J Gastroenterol Date: 2017-05-21 Impact factor: 5.742